• OXYBUTYNIN CHEMBL1231 FDA Approved

    Alternate Names:

    Promictuline
    Kentera
    Urimin
    Contimin 2.5
    Contimin 5
    Lyrinel XL
    Cystrin
    Ditropan XL
    Ditropan
    Oxybutynin
    Oxytrol
    Oxytrol For Women
    Anturol
    4-(DIETHYLAMINO)BUT-2-YNYL 2-CYCLOHEXYL-2-HYDROXY-2-PHENYLACETATE
    BPBIO1_000214
    AC-2153
    CYCLOHEXANEGLYCOLIC ACID, ALPHA-PHENYL-, 4-(DIETHYLAMINO)-2-BUTYNYL ESTER
    PRESTWICK2_000287
    PRESTWICK0_000287
    OXYBUTYNIN TOPICAL GEL
    TRANSDERMAL PATCH
    OXYBUTYNINUM [INN-LATIN]
    OXYTROL (TN)
    BRD-A65013509-003-03-8
    OXYBUTYNINE [INN-FRENCH]
    OXIBUTYNINUM
    DITROPAN, LYRINEL XL, OXYTROL, OXYBUTYNIN
    1508-65-2 (HYDROCHLORIDE)
    OXIBUTININA [INN-SPANISH]
    UNII-K9P6MC7092
    OXYBUTININ
    OXYBUTYNIN BASE
    BENZENEACETIC ACID, ALPHA-CYCLOHEXYL-ALPHA-HYDROXY-, 4-(DIETHYLAMINO)-2-BUTYNYL ESTER
    CID4634
    OXYBUTYNINUM
    164556
    4-(DIETHYLAMINO)-2-BUTYNYL-ALPHA-PHENYLCYCLOHEXANEGLYCOLATE
    L000923
    C07360
    S1754_SELLECK
    5633-20-5
    4-DIETHYLAMINO-2-BUTINYL ALPHA-CYCLOHEXYLMANDELAT
    NCGC00015767-06
    NCGC00089795-02
    AC1L1ILV
    DB01062
    4-(DIETHYLAMINO)-2-BUTYNYL ALPHA-PHENYLCYCLOHEXANEGLYCOLIC ACID ESTER
    SPBIO_002413
    CCRIS 1923
    OXYBUTYNIN (USAN/INN)
    BSPBIO_000194
    HSDB 3270
    I06-2117
    MOLPORT-003-849-741
    PRESTWICK3_000287
    DAP001128
    LOPAC0_000923
    OXYBUTYNIN [USAN:INN:BAN]
    CHEBI:7856
    4-DIETHYLAMINO-2-BUTYNYL ALPHA-PHENYLCYCLOHEXANEGLYCOLATE
    OXYBUTYNINE
    4634
    FT-0082890
    OXIBUTININA
    POLLAKISU
    PRESTWICK1_000287
    LS-28714
    4-(DIETHYLAMINO)-2-BUTYNYL-ALPHA-CYCLOHEXYL-ALPHA-HYDROXYBENZENEACETATE
    4-(DIETHYLAMINO)BUT-2-YN-1-YL CYCLOHEXYL(HYDROXY)PHENYLACETATE
    D00465
    CYCLOHEXANEGLYCOLIC ACID, .ALPHA.-PHENYL-, 4-(DIETHYLAMINO)-2-BUTYNYL ESTER
    135650784
    359
    178101352
    [3H]GLUTAMINE
    4-DIETHYLAMINOBUT-2-YNYL 2-CYCLOHEXYL-2-HYDROXY-2-PHENYLACETATE
    4-(DIETHYLAMINO)BUT-2-YNYL 2-CYCLOHEXYL-2-HYDROXY-2-PHENYL-ACETATE
    4-(DIETHYLAMINO)-2-BUTYNYL CYCLOHEXYL(HYDROXY)PHENYLACETATE #
    4-(DIETHYLAMINO)-2-BUTYNYL .ALPHA.-PHENYLCYCLOHEXANEGLYCOLATE
    3B2-0726
    27815-EP2314587A1
    27815-EP2298767A1
    27815-EP2280008A2
    27815-EP2275420A1
    27815-EP2269989A1
    K-9978
    ST24048863
    AB2000274
    AB0013281
    SMR001550466
    SC-26752
    OR285581
    O222
    LP048773
    DR001867
    AN-14276
    AK162584
    NCGC00015767-09
    NCGC00015767-07
    NCGC00015767-04
    NCGC00015767-03
    OXYBUTYNIN-SUPPLIED BY SELLECK CHEMICALS
    MCULE-3407007074
    KS-5221
    CS-2255
    CCG-205005
    AKOS015896242
    BDBM50165019
    HY-B0267
    OXYBUTYNIN, OXYBUTYNIN CHLORIDE
    MLS006010052
    GTPL359
    DITROPAN;LYRINEL XL;OXYTROL
    SCHEMBL2992
    OXYBUTYNIN TRANSDERMAL PATCH
    OXYBUTYNIN TRANSDERMAL
    (+/-)-OXYBUTYNIN
    ANTUROL (TN)
    LENDITRO
    DITROPANREG
    CYSTRINREG
    4-(DIETHYLAMINO)BUT-2-YN-1-YL 2-CYCLOHEXYL-2-HYDROXY-2-PHENYLACETATE
    XIQVNETUBQGFHX-UHFFFAOYSA-N

    Drug Info:

    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications for treatment of overactive bladder
    FDA Approval not approved
    Drug Indications for treatment of incontinence
    Drug Class antispasmodics
    Year of Approval 1975
    (2 More Sources)

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False
    Direct Interaction? True

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Muscarinic acetylcholine receptor M2 antagonist
    Direct Interaction yes
    Specific Action of the Ligand Antagonist

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False
    Direct Interaction? True

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False
    Direct Interaction? False

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Direct Interaction? False
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False

    Publications:

    • Version: 01-August-2011

    Alternate Names:
    OXYBUTYNIN Primary Drug Name

    Drug Info:
    Year of Approval 1975
    Drug Class antispasmodics

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications for treatment of incontinence
    Drug Class Small molecule
    FDA Approval not approved

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    CYCLOHEXANEGLYCOLIC ACID, .ALPHA.-PHENYL-, 4-(DIETHYLAMINO)-2-BUTYNYL ESTER Drug Synonym
    D00465 Drug Synonym
    4-(DIETHYLAMINO)BUT-2-YN-1-YL CYCLOHEXYL(HYDROXY)PHENYLACETATE Drug Synonym

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    OXYBUTYNIN GuideToPharmacology Ligand Name
    135650784 PubChem Drug SID

    Drug Info:

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    OXYBUTYNIN pubchem_primary_name
    4634 PubChem CID
    5633-20-5 Drug Synonym

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: